A randomized controlled study of Qinqiao Xiaodu granules in the treatment of influenza
Phase 1
Recruiting
- Conditions
- Influenza
- Registration Number
- ITMCTR2100004554
- Lead Sponsor
- Beijing institute of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- Not specified
Inclusion Criteria
1. Confirmed cases of influenza;
2. Patients aged >= 15 years and <= 85 years;
3. Patients whose course of disease is less than or equal to 36 hours;
4. Patients with body temperature >= 37.5 degrees C;
5. Patients who can accept examination, treatment and follow-up, and agree to sign informed consent.
Exclusion Criteria
1. Pregnant women or puerperal women;
2. Patients with mental illness or others who are unable or unwilling to cooperate;
3. Those who have been participating in similar clinical trials in the past one month;
4. Patients with human acquired immunodeficiency syndrome;
5. Patients with influenza have been treated with antiviral drugs.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Complete antipyretic time;
- Secondary Outcome Measures
Name Time Method Microecological changes of upper respiratory tract;Blood routine test;Incidence of common complications of influenza;Total duration of influenza;liver and kidney function;Influenza virus negative time;Drug combination;Differences of endogenous metabolites in serum;Influenza symptom remission score;